Peter P. Pfreundschuh

Chief Financial Officer, IMMUNOMEDICS INC.

Companies

Y-mAbs Therapeutics, Inc.Chief financial officer Jul 8, 2024 to now¹
Voyager Therapeutics (United States)Chief financial officer Sep 21, 2022 to Feb 22, 2024²
Korro Bio, Inc.Chief financial officer Dec 3, 2020 to Feb 23, 2022³
UroGen Pharma Ltd.Chief financial officer Jan 10, 2019 to Oct 16, 2020⁴
Sucampo PharmaceuticalsChief financial officer Mar 22, 2017 to Feb 13, 2018⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Voyager Therapeutics (United States) VYGR175,669 shares⁶$360.1K at $2.05Feb 21, 2024
Korro Bio, Inc. KRRO8,927 shares⁷$83.1K at $9.31Feb 22, 2022
Y-mAbs Therapeutics, Inc.0 shares⁸Sep 16, 2025

As of each latest filing. The line shows shares held over time.

Sep 16, 2025Returned to company 77,800 shares of Y-mAbs Therapeutics, Inc.⁸
Jan 17, 2025Granted 31,800 shares of Y-mAbs Therapeutics, Inc.⁹
Jul 12, 2024Granted 46,000 shares of Y-mAbs Therapeutics, Inc.¹⁰
Feb 21, 2024Sold 3,764 shares at $7.46 of Voyager Therapeutics (United States)⁶
Feb 9, 2024Granted 30,000 shares of Voyager Therapeutics (United States)¹¹
Oct 3, 2023Sold 13,567 shares at $6.99 of Voyager Therapeutics (United States)¹²
Feb 17, 2023Granted 38,000 shares of Voyager Therapeutics (United States)¹³
Oct 1, 2022Granted 125,000 shares of Voyager Therapeutics (United States)¹⁴
Feb 22, 2022Sold 1,542 shares at $3.53 of Korro Bio, Inc.⁷
Feb 18, 2022Sold 1,404 shares at $3.88 of Korro Bio, Inc.⁷
Feb 17, 2022Sold 1,296 shares at $4.20 of Korro Bio, Inc.¹⁵
Feb 16, 2022Sold 1,229 shares at $4.43 of Korro Bio, Inc.¹⁵
Feb 15, 2022Sold 1,347 shares at $4.33 of Korro Bio, Inc.¹⁶
Feb 14, 2022Exercised options 15,000 shares of Korro Bio, Inc.¹⁶

The numbers on this page point here. Each one links to the record it came from.